In the landscape of molecular biology and immunological research, the OVA N4 peptide stands out as a fo Peptides: Emerging Candidates for the Prevention and Treatment of undational tool. Often discussed in the context of OVA (257-264), this specific sequence—frequently referred to by its single-letter amino aci OVA Peptide (323-339) d code, SIINFEKL—serves as a high-precision instrument for those studying cellular interactions. Whether you are exploring the nuances of Ova-based models or comparing the efficacy of various peptides, understanding the biochemical profile of this molecule is essential.
The Biochemical Foundation of OVA N4
The OVA N4 peptide is an octameric sequence d OVA Peptide (257-264) erived from the ovalbumin protein, which is naturally occurring in egg whites. In laboratory settings, ovalbumin is a T cell-dependent antigen that has been widely utilized for decades. The N4 designation typically refers to the wild-type sequence of the OVA 257-264 (SIINFEKL) epitope.
This ovalbumin-derived peptide is classified as a class I (Kb)-restricted epitope. It is presented by the class I MHC (major histocompatibility complex) molecule, specifically H-2Kb. Because of its high binding affinity and stability, researchers often select high-purity OVA (257-264) peptide to ensure reproducibility in their experimental setups.
Applications and Experimental Utility
When working with OVA peptides, the primary objective for many is to observe OVA Antigens how these sequences interact with specific immune receptors. For instance, OVA (257-264) is frequently employed in studies involving OT-I CD8+ T cells. The precision of the SIINFEKL sequence allows for the quantification of peptide epitope specificity, often measured via ELISPOT assays or flow cytometry.
It is worth noting that OVA peptide mainly exists in egg white, but the synthetic versions used in labs are processed to achieve high purity, free from the complexities of the whole albumin (OVA), a major allergen protein present in egg whites. This purity is critical, especially when comparing the N4 epitope to variants like APLova (altered peptide ligands), which may exhibit different binding kinetics or T-cell activation thresholds.
Beyond the N4 Epitope: Exploring Variations
While the N4 sequence is the "gold standard," research often involves studying the structural variations of the OVA peptide. For example, the Ovalbumin(323-339) peptide is another critical sequence, often used to study CD4+ T cell activation and the development of hypersensitivity models.
When re OVA peptide is a class I (Kb)-restricted peptide epitope of ovalbumin, it is presented by the class I MHC (major histocompatibility complex) molecule, viewing literature, you will encounter various OVA peptide derivatives:
* OVA-G4 (SIIGFEKL): A common variant used to test the impact of amino acid substitution on MHC binding.
* OVA-Q4 (SIIQFEKL): Another variant often compared against the wild-type N4 to observe the "curtailed" response in T cells with lower affinity.
Practical OVA Peptide (257-264) is an MHC Class I (Kb) -restricted OVA polypeptide epitope, an octapeptide derived from ovalbumin presented by Class I MHC molecule H-2Kb. Considerations for Researchers
If you are sourcing Ova peptide (257-264), you will find it listed by numerous global suppliers. The molecular formula, C45H74N10O13, is a standard identifier for the SIINFEKL sequence. Researchers should prioritize suppliers that provide high-performance liquid chromatography (HPLC) data to verify the purity of the OVA Peptide (257-264).
Furthermore, Ovalbumin has long been used as an antigen in pre-clinical allergic disease research. Because OVA is a T cell-dependent antigen, it remains the preferred choice for standardiz Defined Immune Response Tracking in Mice: OVA MHC ed testing. Whether you are performing assays where the OVA peptide is used to stimulate T cells in PBMCs or investigating the immunogenicity of new epitopes, the OVA 257-264 (SIINFEKL) remains the benchmark against which other molecules are measured.
Conclusion
The study of OVA peptide—specifically the N4 variant—remains a cornerstone of modern immunological investigation. By focusing on high-quality reagents and understanding the structural distinctions between s I-Ab | chicken OVA 325-335 | QAVHAAHAEIN equences like OVA peptide 323-339 and the OVA (257-264) epitope, researchers can continue to refine their experimental models. As with any specialized reagent, the key to successful research lies in the consistency and purity of the OVA Peptide(257-264) chosen for the study.